NASDAQ
Rennova Health, Inc. (RNVA) has a price/fcf ratio of 1.08x as of Monday, May 25, 2026. This represents a 10472.39% increase compared to its 12-month average of -0.01x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.